Clinical Trials

1,200 enrolled

Disease, Lung Neoplasms

NCT06996249 2026-03-03

DuTOC

Other solid neoplasmThoracic

12,000 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Mesothelioma, Thymus Neoplasms

NCT06016569 2026-02-12

Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.

3,200 enrolled

Phase EARLY_PHASE1 Recruiting

Lung Neoplasms

NCT07236177 2026-02-05

B-GLUCANCER2

220 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT06481813 2026-01-21

BREATHE

730 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT02630615 2025-12-17

Circulating Tumor Cells (CTC) in Lung Cancer

80 enrolled

Lung Neoplasms, Neoplastic Cells, Circulating

NCT05267041 2025-11-21

ULYSSE

4,000 enrolled

Lung Neoplasms

NCT04968548 2025-11-04

Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening

Active not recruiting

5,000 enrolled

Lung Neoplasms

NCT05020275 2025-08-15

RESISTYR

Active not recruiting

60 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06122077 2025-08-05

PROACT-LUNG

20,000 enrolled

Emphysema, Lung Neoplasms, Respiratory Distress Syndrome, Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic

NCT07087080 2025-07-31

Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules

350 enrolled

Solitary Pulmonary Nodule, Lung Neoplasms, Multiple Pulmonary Nodules

NCT06620835 2025-07-29

OPTALK

Phase 2 Recruiting

45 enrolled

Phase NA Not yet recruiting

Lung Neoplasms

NCT07085429 2025-07-25

BCBPoumon

750 enrolled

Carcinoma, Bronchogenic, Lung Neoplasms

NCT05092009 2025-07-15

IPON-3

600 enrolled

Lung Neoplasms

NCT06896162 2025-07-11

PROGRESS

BreastGastrointestinalGenitourinaryThoracic

500 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT00568490 2025-07-02

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

Phase NA Active not recruiting

200 enrolled

Head & NeckThoracic

Head and Neck Neoplasms, Lip Neoplasms, Lung Neoplasms

NCT02597738 2025-06-19

A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine

330 enrolled

Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms

NCT02662621 2025-06-05

EXODIAG

Phase NA Completed

71 enrolled

BreastGynecologicThoracic

Breast Neoplasms, Disease, Lung Neoplasms, Neoplasms, Ovarian Neoplasms

NCT06332274 2025-05-13

UMBRELLA

Phase 3 Recruiting

717 enrolled

GastrointestinalSarcomaThoracic

Colonic Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT04025541 2025-04-02

ALCINA2